FAZIO, FERRUCCIO
 Distribuzione geografica
Continente #
NA - Nord America 43.424
AS - Asia 19.931
EU - Europa 15.788
SA - Sud America 2.712
AF - Africa 368
Continente sconosciuto - Info sul continente non disponibili 32
OC - Oceania 29
Totale 82.284
Nazione #
US - Stati Uniti d'America 41.682
SG - Singapore 7.273
CN - Cina 4.970
HK - Hong Kong 3.128
SE - Svezia 2.689
RU - Federazione Russa 2.631
UA - Ucraina 2.307
BR - Brasile 2.097
IE - Irlanda 2.036
VN - Vietnam 1.992
DE - Germania 1.828
CA - Canada 1.558
IT - Italia 1.413
GB - Regno Unito 941
FR - Francia 714
FI - Finlandia 586
IN - India 462
KR - Corea 384
BD - Bangladesh 309
AR - Argentina 254
TR - Turchia 219
NL - Olanda 200
IQ - Iraq 191
JP - Giappone 142
ZA - Sudafrica 131
PK - Pakistan 127
MX - Messico 110
EC - Ecuador 104
SA - Arabia Saudita 101
ID - Indonesia 88
PH - Filippine 85
PL - Polonia 79
UZ - Uzbekistan 68
CO - Colombia 66
VE - Venezuela 59
ES - Italia 57
MA - Marocco 50
BE - Belgio 49
MY - Malesia 49
AT - Austria 43
CL - Cile 41
TH - Thailandia 38
KE - Kenya 37
IR - Iran 35
AE - Emirati Arabi Uniti 32
PY - Paraguay 32
KZ - Kazakistan 28
NP - Nepal 28
ET - Etiopia 27
IL - Israele 27
EU - Europa 26
PE - Perù 26
TN - Tunisia 26
DK - Danimarca 22
EG - Egitto 22
OM - Oman 22
CH - Svizzera 21
RO - Romania 21
UY - Uruguay 20
DZ - Algeria 19
AZ - Azerbaigian 17
JO - Giordania 17
LT - Lituania 17
GR - Grecia 16
PS - Palestinian Territory 16
PT - Portogallo 16
AU - Australia 15
BG - Bulgaria 13
CZ - Repubblica Ceca 13
BO - Bolivia 12
DO - Repubblica Dominicana 12
JM - Giamaica 12
AL - Albania 11
CR - Costa Rica 11
KW - Kuwait 11
LB - Libano 11
NZ - Nuova Zelanda 11
BH - Bahrain 9
KG - Kirghizistan 9
NG - Nigeria 9
BA - Bosnia-Erzegovina 8
HU - Ungheria 8
HN - Honduras 7
PA - Panama 7
RS - Serbia 7
TT - Trinidad e Tobago 7
AO - Angola 6
BY - Bielorussia 6
GE - Georgia 6
LY - Libia 6
MK - Macedonia 6
TW - Taiwan 6
A2 - ???statistics.table.value.countryCode.A2??? 5
NO - Norvegia 5
EE - Estonia 4
GT - Guatemala 4
LV - Lettonia 4
MD - Moldavia 4
MU - Mauritius 4
NI - Nicaragua 4
Totale 82.194
Città #
Ann Arbor 4.865
Woodbridge 4.590
Singapore 3.908
Houston 3.460
Ashburn 3.379
Hong Kong 3.087
Fairfield 2.971
Jacksonville 2.560
Chandler 1.981
Dublin 1.919
Dearborn 1.427
San Jose 1.248
Wilmington 1.176
Seattle 1.073
New York 998
Cambridge 975
Toronto 917
Princeton 848
Frankfurt am Main 824
Santa Clara 796
Hefei 732
Chicago 647
The Dalles 635
Beijing 615
Ho Chi Minh City 556
Dallas 478
Nanjing 457
Hanoi 438
Lawrence 423
Lachine 421
Altamura 413
Lauterbourg 371
Seoul 366
Los Angeles 364
Shanghai 312
Milan 303
Moscow 285
San Diego 204
Buffalo 194
São Paulo 191
Council Bluffs 190
Shenyang 179
Changsha 152
Nanchang 142
Huizen 136
Andover 135
Helsinki 135
Boardman 130
Guangzhou 129
Munich 128
Hebei 120
Tianjin 111
Jiaxing 104
London 102
Dong Ket 100
Falls Church 97
Mountain View 93
Ottawa 89
Tokyo 84
Baghdad 79
Haiphong 77
Da Nang 76
Jinan 73
Zhengzhou 73
Salt Lake City 71
Rio de Janeiro 60
Tashkent 57
Philadelphia 55
Dhaka 54
University Park 52
Norwalk 50
Orem 50
Warsaw 49
Johannesburg 47
Ningbo 47
Columbus 46
Hangzhou 46
Brussels 44
Chennai 44
Jeddah 43
Phoenix 43
Nürnberg 42
Lahore 41
Elk Grove Village 40
Auburn Hills 39
Detroit 38
Belo Horizonte 37
Brooklyn 37
Rome 37
Tampa 37
Montréal 36
Amsterdam 35
Brasília 35
Curitiba 35
Fremont 35
Quito 35
Porto Alegre 34
Taizhou 34
Montreal 33
San Mateo 33
Totale 55.692
Nome #
Synthesis, labeling, and biological evaluation of halogenated 2-quinolinecarboxamides as potential radioligands for the visualization of peripheral benzodiazepine receptors 515
Economic analyses on the use of positron emission tomography for the work-up of solitary pulmonary nodules and for staging patients with non-small-cell-lung-cancer in Italy 494
Evaluation of three quinoline-carboxamide derivatives as potential radioligands for the in vivo pet imaging of neurodegeneration 450
11C-Labelling of N-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butyl]arylcarboxamide Derivatives and Evaluation as Potential Radioligands for PET imaging of Dopamine D3 Receptors 447
Cholinergic ligand [C-11]MP4A: Improved 4-acetoxypiperidine precursor synthesis via LC-APCI/MS characterisation and improved radioligand HPLC purification 441
In vivo imaging of adenosine A2A receptors in rat and primate brain using [11C]SCH442416 439
11C-radiosynthesis and preliminary human evaluation of the disposition of the ACE inhibitor [11C]Zofenoprilat 390
FDG/PET and spiral CT image fusion for medistinal lymph node assessment of non-small cell lung cancer patients 382
Functional heterogeneity of left inferior frontal cortex as revealed by fMRI 351
Characterization of biological features of a rat F98 GBM model: a PET-MRI study with [18F]FAZA and [18F]FDG 349
Improved synthesis and radiolabeling of [C-11]MP4A, a suitable ligand for the investigation of the cholinergic system using PET 348
Time course of metabolic activity and cellular infiltration in a murine model of acid-induced lung injury 346
Perfusion CT in cirrhotic patients with early stage hepatocellular carcinoma: Assessment of tumor-related vascularization 340
Changes in glucose metabolism during and after radiotherapy in non-small cell lung cancer 319
Choline and phosphatidylcholine fluorescent derivatives localization in carcinoma cells studied by laser scanning confocal fluorescence microscopy 314
Synthesis and in vivo evaluation of 3-[C-11]methyl-(3-methoxy-naphthalen)-2-yl-(1-benzyl-piperidin)-4-yl-acetate (SB-235753), as a putative dopamine D-4 receptors antagonist for PET 313
Non-peptide NK1 receptor ligands based on the 4-phenylpyridine moiety 313
Multi-modal medical image integration to optimize radiotherapy planning in lung cancer treatment 312
Monitoring disease evolution and treatment response in lysosomal disorders by the peripheral benzodiazepine receptor ligand PK11195 312
11C-Choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy 310
Lungs of patients with acute respiratory distress syndrome show diffuse inflammation in normally aerated regions: A [18F]-fluoro-2-deoxy-D-glucose PET/CT study 308
Evaluation of the role of tumor-associated macrophages in an experimental model of peritoneal carcinomatosis using 18F-FDG PET 308
Quinolinic acid induced neurodegeneration in the striatum: a combined in vivo and in vitro analysis of receptor changes and microglia activation 305
Performance evaluation of the new whole-body PET/CT scanner: Discovery ST 304
Characterization of preclinical models of prostate cancer using PET-based molecular imaging 303
C-11 choline versus F-18 fluorodeoxyglucose for imaging meningiomas: An initial experience 303
[11C]RN5: A new agent for the in vivo imaging of myocardial α1-adrenoceptors 299
4D-PET data sorting into different number of phases: a NEMA IQ phantom study 298
Automated production of copper radioisotopes and preparation of high specific activity [(64)Cu]Cu-ATSM for PET studies 296
Hepatocellular carcinoma treated with transarterial chemoembolization: Dynamic perfusion-CT in the assessment of residual tumor 292
Patients with known or suspected lung cancer: evaluation of clinical management changes due to f-fluorodeoxyglucose positron emission tomography (f-fdg pet) study 291
Hepatocellular carcinoma in cirrhotic liver disease: functional computed tomography with perfusion imaging in the assessment of tumor vascularization 290
The p53-p66Shc apoptotic pathway is dispensable for tumor suppression whereas the p66Shc-generated oxidative stress initiates tumorigenesis 288
Fluoro-deoxi-glucose uptake and angiogenesis are independent biological features in lung metastases 287
Comparison of 18F-fluoroazomycin-arabinofuranoside and 64Cu-diacetyl-bis(N4-methylthiosemicarbazone) in preclinical models of cancer 285
Acupuncture produces central activations in pain regions 284
Left caloric vestibular stimulation ameliorates right hemianesthesia 284
Perfusion computed tomographic assessment of early hepatocellular carcinoma in cirrhotic liver disease: initial observations 281
Basal ganglia and language: Phonology modulates dopaminergic release 273
Localization of grasp representations in humans by PET: 1. Observation versus execution 272
Synthesis and in vivo evaluation of [11C]ICI 118551 as a putative subtype selective β2-adrenergic radioligand 268
A publicly accessible Monte Carlo database for validation purposes in emission tomography 267
Data rebinning and reconstruction in 3D PET/CT oncological studies: a Monte Carlo evaluation. 267
Synthesis and carbon-11 labeling of (R)- and (S)-Thionisoxetine, norepinephrine reuptake inhibitors, potential radioligands for Positron Emission Tomography 266
Lesion detectability and quantification in PET/CT oncological studies by Monte Carlo simulations 264
Pre-transplant 18FDG-PET predicts outcome in lymphoma patients treated with high-dose sequential chemotherapy followed by autologous stem cell transplantation 264
Positron emission tomography/computed tomography introduction in the clinical management of patients with suspected recurrence of ovarian cancer: A cost-effectiveness analysis 260
Positron emission tomography in neuronal ceroid lipofuscinosis (Jansky-Bielschowsky disease): a case report 259
Assessment of myocardial perfusion and viability with technetium-99m methoxyisobutylisonitrile and thallium-201 rest redistribution in chronic coronary artery disease 258
Asymmetric synthesis and preliminary evaluation of (R)- and (S)-[11C]bisoprolol, a putative beta1-selective adrenoceptor radioligand 257
High-resolution SPECT study of regional cerebral blood flow in drug-free and drug-naive schizophrenic patients 257
Supercalifragilisticexpialidocious: How the brain learns words never heard before 257
Myocardial insulin resistance associated with chronic hypertriglyceridemia and increased FFA levels in Type 2 diabetic patients 256
Progressive dysphasic dementia with bucco-facial apraxia: A case report 256
Development of a bicistronic vector for multimodality imaging of estrogen receptor activity in a breast cancer model: preliminary application 254
A voxel-based PET study of dopamine transporters in Parkinson's disease: relevance of age at onset 254
Radiosynthesis of [123I]βCIT, a selective ligand for the study of the dopaminergic and serotoninergic systems in human brain 254
SPET imaging of cerebral perfusion in patients with non‐refractory temporal lobe epilepsy 251
Evaluation of pre- and post-reconstruction count-dependent Metz filters for brain PET studies 250
Isolated amnesia with slow onset and stable course, without ensuing dementia: MRI and PET data and a six-year neuropsychological follow-up 250
A Monte Carlo model of noise components in 3-D PET 249
Syntax and the brain: Disentangling grammar by selective anomalies 246
Whole-body scintigraphy with 99Tcm-mibi, 18f-fdg and 131I in patients with metastatic thyroid carcinoma 246
Predictive factors of [(11)C]choline PET/CT in patients with biochemical failure after radical prostatectomy 246
Cost-effectiveness analysis in the clinical management of patients with known or suspected lung cancer: [(18F)]fluorodeoxyglucose PET and CT comparison 245
GABAa receptor abnormalities in Prader-Willi syndrome assessed with positron emission tomography and [11C]flumazenil 244
Mri, antibody-guided scintigraphy, and glucose metabolism in uveal melanoma 244
Increased C-11 choline uptake in pagetic bone in a patient with coexisting skeletal metastases from prostate cancer 243
Labeling and evaluation of N-[11C]methylated quinoline-2-carboxamides as potential radioligands for visualization of peripheral benzodiazepine receptors 242
An automatic classification technique for attenuation correction in positron emission tomography 241
Myocardial glucose uptake evaluated by positron emission tomography and fluorodeoxyglucose during hyperglycemic clamp in IDDM patients: Role of free fatty acid and insulin levels 241
Nonpalpable breast lesions: preoperative radiological guidance in radioguided occult lesion localisation (ROLL). Lesioni mammarie non palpabili: la guida radiologica preoperatoria nella ROLL (radioguided occult lesion localisation) 240
Integrated PET/CT as a first-line re-staging modality in patients with suspected recurrence of ovarian cancer 239
Post-therapy surveillance of patients with uterine cancers: value of integrated FDG PET/CT in the detection of recurrence 239
Relation between dobutamine trans-thoracic echocardiography, 99Tcm-MIBI and 18FDG uptake in chronic coronary artery disease 239
Head holder for PET, CT, and MR studies 239
A modified damped Richardson-Lucy algorithm to reduce isotropic background effects in spherical deconvolution 239
PET and SPET molecular imaging: Focus on serotonin system 238
Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease 238
Determination of extravascular lung water by dilution methods. I. Theoretical considerations 238
In vivo serotonin 5HT(2A) receptor binding and personality traits in healthy subjects: a positron emission tomography study 237
Acute effect of 3-(4-acetamido)-butyrril-lorazepam (dds2700) on brain function assessed by pet at rest and during attentive tasks 237
The role of age of acquisition and language usage in early, high-proficient bilinguals: an fMRI study during verbal fluency 237
Pathways of interhemispheric transfer in normals and in a split-brain subject. A positron emission tomography study 237
Errors introduced by tissue heterogeneity in estimation of local cerebral glucose utilization with current kinetic models of the [18F]fluorodeoxyglucose method 236
Preserved functional competence of perilesional areas in drug-resistant epilepsy with lesion in supplementary motor cortex: fMRI and neuropsychological observations. 236
Synthesis and Biodistribution of (R,S)-[O-Methyl-11C]-1-[3-(5-Methoxy-1,2,3,4-Tetrahydro-1-Naphtalenyl)Propyl]-4-Phenylpiperazine (PNU-157760), A Putative Radioligand for 5-HT1A Receptors 236
Positron emission tomograhy for the assessment of myocardial viability: A sinopsys of methods and indications 235
Systemic and cerebral kinetics of 16α[18F]fluoro-17β-estradiol: A ligand for the in vivo assessment of estrogen receptor binding parameters 235
Preparation of [11C]radioligands with high specific radioactivity on a commercial PET tracer synthesizer 235
Left and right hemisphere contribution to recovery from neglect after right hemisphere damage--an [18F]FDG pet study of two cases 235
Remodelling of sensorimotor maps in paraplegia: a functional magnetic resonance imaging study after a surgical nerve transfer 234
[(11)C]Choline uptake with PET/CT for the initial diagnosis of prostate cancer: relation to PSA levels, tumour stage and anti-androgenic therapy 234
Two-step tumour targetting in ovarian cancer patients using biotinylated monoclonal antibodies and radioactive streptavidin 234
Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology 233
Synthesis and Biological Characterization of Novel 2-Quinolinecarboxamide Ligands of the Peripheral Benzodiazepine Receptors Bearing Technetium-99m or Rhenium 233
Sensitive GC-MS method for the determination of specific-activity of 16a[18F]Fluoro-estra-1,3,5(10)-triene-3,17b-diol 233
Metabolic imaging of uveal melanoma using positron emission tomography 233
Identification and revascularization of hibernating myocardium inangina-free patients with left ventricular dysfunction 232
Metabolic impairment in human amnesia: a PET study of memory networks 232
Totale 28.035
Categoria #
all - tutte 271.244
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 271.244


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021501 0 0 0 0 0 0 0 0 0 0 161 340
2021/20224.752 186 478 767 563 272 238 218 263 263 271 414 819
2022/20237.521 1.043 2.344 421 658 580 1.234 98 330 499 34 207 73
2023/20244.881 163 159 171 145 780 1.374 1.055 122 464 21 46 381
2024/202510.645 717 1.586 405 456 951 270 340 499 1.200 1.360 917 1.944
2025/202623.375 2.073 1.952 2.089 2.601 2.520 1.530 3.377 1.592 2.274 1.985 1.382 0
Totale 82.664